Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers reported at a conference in Vienna.

Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S‘ (NYSE:NVO) Rybelsus (oral ...

Retiring in 1960 was quite different than it is today, with major changes in Social Security and the frequency of pensions ...